https://farmindustria.wp.ubqlab.app/documenti/position-paper-malattie-rare-2024/2026-08-25T14:07:10+02:00https://farmindustria.wp.ubqlab.app/documenti/executive-summary-malattie-rare/2026-08-25T14:07:10+02:00https://farmindustria.wp.ubqlab.app/documenti/documento-di-comunicazione-malattie-rare/2026-08-25T14:07:11+02:00https://farmindustria.wp.ubqlab.app/documenti/position-paper-plasmaderivati-2023/2026-08-25T14:07:11+02:00https://farmindustria.wp.ubqlab.app/documenti/raccomandazioni-contrasto-amr/2026-08-25T14:07:11+02:00https://farmindustria.wp.ubqlab.app/documenti/digital-therapeutics-working-paper-2023/2026-08-25T14:07:11+02:00https://farmindustria.wp.ubqlab.app/documenti/real-world-evidence/2026-08-25T14:07:11+02:00https://farmindustria.wp.ubqlab.app/documenti/position-statement-terapie-avanzate-atmp/2026-08-25T14:07:11+02:00https://farmindustria.wp.ubqlab.app/documenti/position-paper-biosimilari/2026-08-25T14:07:11+02:00https://farmindustria.wp.ubqlab.app/documenti/documento-ricerca-preclinica/2026-08-25T14:07:11+02:00https://farmindustria.wp.ubqlab.app/documenti/privacy-e-sperimentazione-clinica/2026-08-25T14:07:11+02:00